# Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors

> **NCT00426582** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 48 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Patupilone

## Key facts

- **NCT ID:** NCT00426582
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2010-08
- **Final completion:** —
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00426582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00426582, "Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00426582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*